|
Volumn 35, Issue 3, 2012, Pages 319-326
|
PLGA 50:50 nanoparticles of paclitaxel: Development, in vitro anti-tumor activity in BT-549 cells and in vivo evaluation
|
Author keywords
BT 549 cells; Paclitaxel; Pharmacokinetics; PLGA 50:50
|
Indexed keywords
ANTI-TUMOR ACTIVITIES;
BREAST CANCER TREATMENT;
BURST RELEASE;
CELL LINES;
CLEARANCE RATES;
DRUG DELIVERY SYSTEM;
EMULSION SOLVENT EVAPORATION;
ENCAPSULATION EFFICIENCY;
HYDROPHOBIC DRUG;
IN-VITRO;
IN-VIVO;
PACLITAXEL;
PHARMACOKINETIC PROFILES;
PHYSICOCHEMICAL PARAMETERS;
PLGA 50:50;
PLGA NANOPARTICLES;
CELL CULTURE;
DRUG DELIVERY;
EMULSIFICATION;
ENCAPSULATION;
HYDROPHOBICITY;
OPTIMIZATION;
PHARMACOKINETICS;
NANOPARTICLES;
|
EID: 84863495964
PISSN: 02504707
EISSN: None
Source Type: Journal
DOI: 10.1007/s12034-012-0313-7 Document Type: Article |
Times cited : (81)
|
References (22)
|